Philippines vs South Sudan: Population requiring preventive chemotherapy for schistosomiasis
Philippines
3.21 million
in 2024
South Sudan
3.75 million
in 2024
Philippines rank
24th
South Sudan rank
22nd
Population requiring preventive chemotherapy for schistosomiasis over time
- Philippines
- South Sudan
How they compare
South Sudan currently reports 3.75 million against 3.21 million in Philippines, a difference of 541,110.
That makes South Sudan's figure about 1.2 times Philippines's.
The two have swapped places 4 times across 12 shared years of data; in 2013 it was South Sudan ahead.
Philippines ranks 24th and South Sudan ranks 22nd of 52 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Philippines | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.34 million | 2.57 million | 233,420 | South Sudan |
| 2020s | 2.87 million | 3.48 million | 609,066 | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Philippines or South Sudan?
- South Sudan, at 3.75 million against 3.21 million in Philippines as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Philippines and South Sudan?
- 541,110, with South Sudan ahead.
- How many years of comparable data are there for Philippines and South Sudan?
- 12 years are reported by both, from 2013 to 2024.
- How do Philippines and South Sudan rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Philippines ranks 24th and South Sudan ranks 22nd of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.